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Abstract In RCS rats, photoreceptors degenerate between 
postnatal days 20 and 60, secondary to a genetic defect expressed 
in the neonatal retinal pigmented epithelium (RPE). Previous 
work has shown delay of the photoreceptor degeneration in this 
model by intraocular injection of basic fibroblast growth factor 
(BFGF). Evidence is presented here, from bFGF immunostaining 
and Northern analysis of bFGF mRNA, for reduced bFGF 
expression in uncultured RPE of dystrophic RCS pups. It is also 
shown that in the mutant eyes angiogenesis in the underlying 
choroid, which normally occurs between postnatal days 7 and 10, 
is markedly delayed, with irregular distribution of vessels, 
consistent with a reduction in this known angiogenesis factor. 
Mutational analysis of the bFGF transcript and gene by 
denaturing gradient gel electrophoresis and Southern analysis 
did not, however, reveal abnormalities in the coding sequence of 
this gene in RCS rats. 
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1. Introduction 
The Royal College of Surgeons (RCS) rat is a well known 
animal model of inherited retinal degeneration, of unknown 
etiology, in which progressive loss of photoreceptors is evident 
from 20-60 days after birth [l]. The genetic defect was shown 
to be expressed in the retinal pigmented epithelium (RPE), but 
not the photoreceptors themselves, using experimental chi- 
meras in which normal and mutant RPE could be distin- 
guished on the basis of pigmentation [2]. The photoreceptor 
cell death in the RCS retina appears to be secondary to the 
RPE defect, which involves failure to phagocytize renewing 
photoreceptor membranes, which progressively accumulate 
in the subretinal space beginning about postnatal day 12 [l- 
81. The reason for the death of the photoreceptors is at pres- 
ent unknown. 
Basic FGF (bFGF), also known as FGF-2, is a widely 
distributed heparin-binding growth factor, with a very broad 
range of actions (reviewed in [9,10]). During embryogenesis, 
bFGF has been shown to mediate many fundamental proc- 
esses including induction of mesoderm from endoderm, mito- 
genesis in mesoderm- and neuroectoderm-derived cells and 
angiogenesis. In most adult tissues, its distribution is primarily 
confined to extracellular matrix, where it is normally stored in 
an inactive form. Basic FGF is also a neurotrophic factor, 
capable of promoting neuronal cell survival in the visual sys- 
tem and other parts of the central nervous system [l l-131. 
Interest in this factor in relation to retinal degeneration has 
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been greatly stimulated by the observation that injection of 
bFGF into eyes of 23-day-old RCS rats dramatically delays 
the progress of photoreceptor degeneration in these retinas, 
possibly by virtue of its neurotrophic effects [14]. Our focus 
has been to investigate whether bFGF might also be directly 
related to the primary RPE defect in this model. In this study 
we compared bFGF expression in the RPE of normal and 
dystrophic RCS rat pups and, finding evidence of reduced 
bFGF expression in the dystrophic RPE and delayed, abnor- 
mal angiogenesis in the underlying choroid, proceeded to ex- 
amine the bFGF gene for mutations in this mutant. 
2. Materials and methods 
2.1. Experimental animals 
Breeding colonies were maintained by brother x sister matings of 
four RCS rat strains, i.e. tan-hooded retinal dystrophic (RCS) and 
congenic control (RCS-rdy+) and black-hooded (pigmented) dys- 
trophic (RCS-p+) and congenic control (RCS-rdy+p+). Retinal phe- 
notype of breeders and offspring was verified histologically on a rou- 
tine basis. Pups were used for experiments on postnatal days (P) 7-14. 
All animal procedures conformed to the Resolution on the Use of 
Animals in Research of the Association for Research in Vision and 
Ophthalmology. 
2.2. Preparation of rat RPE-lined and choroid-lined eyecups. isolated 
RPE sheets and plated primary RPE cells 
Eyecups used for immunohistochemistry were prepared from eyes 
of P7-14 tan-hooded normal and dystrophic rats. Under a dissecting 
microscope, eyes immersed in Hank’s balanced salt solution (HBSS) 
were carefully trimmed of ocular adnexa, then cut open at the limbus. 
The anterior segment and lens were discarded, the neural retina was 
gently removed from the eyecup, and the exposed RPE monolayer 
was fixed in situ. All other procedures using RPE involved, prior to 
dissection, incubation of eyes in Dispase, which results in clean sep- 
aration of the RPE monolayer from the choroid, as previously de- 
scribed [15-171. The choroid-lined eyecups remaining after removal of 
the RPE were fixed in 2% paraformaldehyde and whole-mounted for 
observation of the choroidal vasculature. Freshly isolated RPE was 
prepared for immunostaining by plating numerous small patches of 
epithelium (average 5 x lo3 cells/well) in &well chamber slides in mini- 
mum essential medium with Earle’s salts (Gibco) + 20% fetal bovine 
serum (FBS) + 1% penicillin/streptomycin, and fixing them following 
attachment to the glass substrate (within 18 h of plating). 
2.3. Immunofuorescent detection of bFGF in rat RPE cells 
RPE-lined eyecups and sheets of freshly isolated RPE cells plated in 
multiwell slides were fixed at room temperature (RT) in 2% or 4% 
paraformaldehyde in O.lM NaP04 buffer, pH 7.4, then washed exten- 
sively in buffer. For immunostaining, whole eyecups were processed 
through droplets of the various solutions, and plated RPE were pro- 
cessed in miltiwell slides. Both types of RPE preparation were ‘first 
incubated for 30 min in PBS + 3% bovine serum albumin (BSA) + 1% 
FBS, then reacted for 1 h at RT with primary antibody against bFGF 
diluted with PBS + 3% BSA, i.e. either (1) rabbit polyclonal antipep- 
tide antibody raised against amino acids l-24 of the human and 
bovine bFGF sequence (Sigma), 1:30 dilution or (2) mouse monoclo- 
nal antibody raised against purified bovine brain bFGF (Upstate Bio- 
technology Inc., type l), 1:50-l :200 dilution. Following washing, 
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bound antibody was detected by incubation with an appropriate 
FITC-labeled secondary antibody, as previously described [18]. Con- 
trols included (1) preadsorption of the antipeptide antibody with a lo- 
fold excess of the corresponding bFGF synthetic peptide (Sigma) for 
24 h at 4°C prior to useand (2) incubation of samples in afi groups 
for 1 h in PBS + 3% BSA alone, followed bv secondarv antibodv. 
After the final washing step in PBS, all preparations were mounted 
in Fluoromount-G (Southern Biotechnology Associates Inc., Birming- 
ham, AL), and slides were observed and photographed by phase con- 
trast and fluorescence microscopy using a Zeiss Photomicroscope III 
as previously described [ 181. 
2.4. Isolation of RNA from uncultured rat RPE cells 
Immediately following isolation, pooled RPE sheets obtained from 
a litter of PlO pigmented normal or dystrophic rat pups (lo-20 eyes; 
0.5-1.0X lo6 RPE cells) were lysed by addition of a 1 ml volume of 
4 M guanidine thiocyanate solution, followed by vigorous vortexing 
and homogenization with a 7 mm Polytron generator. Homogenates 
from each batch of cells were stored at -20°C then 5-7 batches, each 
obtained from pups of a different mother, were combined for RNA 
isolation. Low speed centrifugation was used to remove pigment gran- 
ules and debris, then RNA was purified by CsCl centrifugation as 
described by Chirgwin [19]. Typically, 5-7 pg of purified total RNA 
was obtained from lo6 uncultured neonatal rat RPE cells. To produce 
RNA samples representative of RPE from a large number of rat pups, 
total RNA samples obtained from loo-125 individual eyes were com- 
bined for use on Northern blots. 
2.5. Preparation of RT-PCR-amplified bFGF probe from rat RPE 
PCR primers (sense, nt 254-272; antisense nt 739-720) were de- 
signed from the published rat brain bFGF cDNA sequence [20] 
such that the entire coding sequence would be contained in the frag- 
ment analyzed. Total RNA isolated from cultured BPEI-1 normal rat 
RPE cell line [16] was used for the RT-PCR amplification (GeneAmp 
kit, Perkin-Elmer) with these primers, and the RT-PCR product of 
correct size (486 bp) was purified by gel electrophoresis, confirmed to 
be bFGF by DNA sequencing, and cloned into the pCR-Script SK(+) 
vector (Stratagene). Both the cloned and uncloned RT-PCR product 
were used as hybridization probes after labeling with 32P by random 
oligonucleotide incorporation. 
2.6. Northern analysis of bFGF expression in uncultured rat RPE cells 
RNA (10 pg/lane) isolated from uncultured normal or dystrophic 
rat RPE or confluent cultures of BPEI-1 normal rat RPE cell line, 
grown with cobblestone morphology [ 161, was electrophoresed in for- 
maldehyde gels [21], transferred to nylon filters, baked, and used for 
hybridization with the rat RPE bFGF cDNA probe, and a probe for 
B-actin. The size of the hybridizing species was approximated from the 
positions of the 28s and 18s ribosomal RNAs, and RNA size stand- 
ards (Gibco BRL) co-electrophoresed with the samples. For standard- 
ization of the quantity and quality of RNA present on the blot, 
ethidium bromide staining of the ribosomal RNA and hybridization 
intensities of B-actin message were used as reference. 
2.7. Isolation of DNA and genomic southern blot analysis 
High-molecular-weight genomic DNA was isolated from liver of 
adult control (RCS-rdy+) and RCS rats using proteinase K digestion, 
phenol-chloroform extraction, and ethanol precipitation [22]. 10 pg of 
DNA was double digested with BamHI and another restriction en- 
zyme, i.e. Bgfl, EcoRI, NindIII, KpnI or PstI, then electrophoresed, 
blotted onto a nylon filter, hybridized with 32P-labeled RT-PCR 
bFGF probe, and autoradiographed [23]. 
2.8. Mutational analysis of the bFGF gene and transcript by denaturing 
gradient gel electrophoresis (DGGE) 
The sequence of the rat bFGF gene is not known; in order to 
analyze this gene in the rat, the sequence of the published human 
gene [24] was used as a reference to determine the limits of the pre- 
dicted three exons of the rat gene. As shown in Fig. Sa, PCR primers 
(20 bp) were designed from the rat bFGF cDNA sequence [20] to 
amplify the coding region of the gene sequence contained in the pu- 
tative exons, i.e. nucleotide residues 274408, 449-512, and 553-719. 
For the analysis of the rat bFGF transcript, the rat cDNA sequence 
was divided into two overlapping regions, i.e. Rl (residues 235-512) 
and R2 (residues 341-719) and primers were designed to amplify these 
regions from the RT product of RNA from BPEI-1 normal and 
MGM-1 dystrophic rat RPE cell lines [16]. The Rl and R2 products 
contained the 20 bp of exonic sequence flanking each of the introns, 
missed in the direct amplification of the gene (Fig. 5a). Each PCR 
product also contained a 40-bp G&lamp at either the 5’ or 3’ end to 
increase the detectability of mutations by DGGE [25]. The PCR prod- 
ucts predicted with the designed primers were also analyzed by the 
MELT, MU, and SQHTX computer programs to determine their 
suitability for DGGE analysis [26]. 
The bFGF-coding gene and transcript sequences were amplified by 
PCR from control and RCS genomic DNA or RT-product of RNA, 
respectively, examined by gel electrophoresis to confirm the size, and 
partial DNA sequencing to confirm the identity of the products, and 
analyzed bv DGGE as we have nreviouslv described 127.281. The 
denaturing gradient gels were routmely electrophoresed at SO or 150 
V for 616 h, depending on the condition specified by the computer 
analysis, stained with ethidium bromide, and photographed. To detect 
potentially hidden homozygous mutations involving guanine and cy- 
tosine, samples from dystrophic rats were mixed with corresponding 
normal PCR products and analyzed for heteroduplex formation by 
DGGE. 
3. Results 
The RPE and choroidal melanocytes are amelanotic in the 
pink-eyed, tan-hooded strains of normal and dystrophic RCS 
rats; we took advantage of the lack of pigment in the poster- 
ior eyecup to develop a simple new immunofluorescent tech- 
nique to directly assess the distribution and staining intensity 
of bFGF-positive cells within the intact RPE monolayer, 
which could be viewed en face in whole mounts of RPE-lined 
eyecups. All data were obtained from normal and dystrophic 
RPE samples prepared and immunostained concurrently. Sim- 
ilar results were obtained with both bFGF antibodies. In eye- 
cup preparations from S-day-old normal rats, most of the 
RPE cells in the monolayer were brightly stained following 
reaction with anti-bFGF antibodies (Fig. la). Specificity of 
the reaction was shown by loss of immunostaining with the 
bFGF (l-24) peptide antibody following preadsorption with 
the corresponding peptide (Fig. lb). Controls from all groups 
showed only weak background fluorescence upon omission of 
the primary antibody (Fig. lc). In contrast, the RPE mono- 
layer of 8-day-old mutant rats, when reacted with the bFGF 
antisera, showed very weak immunostaining (Fig. Id) which 
was barely above control levels (Fig. le). In eyecups from lo- 
day-old normal rats, a mixed reaction was seen in which 
about 30-50% of the RPE cells showed a distinct positive 
reaction, whereas in adjacent cells within the epithelium, 
staining was closer to background levels (Fig. If; compare 
with control in Fig. lh). In 12-day-old normal rats, fewer 
RPE cells were immunoreactive with bFGF antibodies (not 
shown). In all of the positively stained normal RPE cells, 
many of which are binucleate in rats, reaction product was 
diffusely distributed throughout the cytoplasm, revealing the 
hexagonal shape of the cells and the one or two unstained 
nuclei (Fig. If). In the dystrophic eyecups, as seen in the 7- 
8-day-old animals, almost no strongly positive cells were ob- 
served in RPE monolayers from lCLlCday-old RCS rats (PlO 
result shown in Fig. lg). 
To ensure that the immunostaining observed in the RPE in 
eyecup preparations was intrinsic to the RPE cells, bFGF 
immunostaining was also performed on small sheets of freshly 
isolated RPE cells from eyes of 7-day-old pigmented normal 
and dystrophic rats. Clumps of isolated RPE cells from nor- 
mal rats of this age were brightly stained (Fig. lij), whereas 
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Fig. 1. Immunofluorescent detection of bFGF in control and dystrophic rat RPE cells. (a-e) Low power views of whole-mounted RPE-lined 
eyecups from tan-hooded P8 normal (ax) and P8 dystrophic (d,e) rats. Two eyecups from one normal animal (a,b) and two samples from a 
mutant pup (d,e) are compared. Samples in (a,d) reacted with anti-bFGF (l-24) antipeptide antiserum; controls in (b,e) reacted with the same 
antiserum preadsorbed with bFGF (l-24) peptide; control in (c) reacted with secondary antibody alone. Arrowheads in (a) indicate sites (dark 
holes) where individual RPE cells have fallen out of the otherwise brightly fluorescent epithelium, revealing the underlying unreactive choroid. 
Note the weak bFGF immunoreactivity in the mutant RPE compared with control (a,d). Bar, 100 pm (ax). (f-h) Higher magnification of eye- 
cups from PlO normal (f,h) and dystrophic (g) rats. Bar, 40 urn (f-h). (f,g) Preparations reacted with monoclonal antibody against bovine brain 
bFGF; (h) control. (i-1) Clumps of isolated RPE cells from pigmented P7 normal (ij) and P7 dystrophic (k,l) rats. Bar, 125 urn (i-l). Cells in 
(i,k) reacted with monoclonal anti-bFGF antiserum; (i,l) show phase contrast images of (i,k), respectively. Strong bFGF immunoreactivity is 
seen only in normal RPE cells in (i). 
sheets of dystrophic cells of comparable appearance were were much weaker than p-actin, a highly expressed transcript 
minimally labeled with the anti-bFGF antibodies (Fig. lk,l). in these cells (Fig. 2a). Densitometric analysis of bFGF ex- 
Northern analysis was used to evaluate the level of expres- pression, normalized to actin, revealed an approximately two- 
sion of bFGF mRNA in RPE of neonatal rat eyes, using 10 fold reduction in bFGF levels in uncultured PlO mutant RPE, 
ug samples of pooled RNA from uncultured normal or dys- as compared with age-matched normal controls (Fig. 2b). 
trophic RPE (representative of approximately 125 eyes of To determine whether the observed decrease in bFGF im- 
each rat strain), and RNA from cultured BPEI-1 normal rat munostaining, and mRNA levels were reflective of a biologi- 
RPE cells for reference (Fig. 2a). The result revealed a faint tally significant difference between normal and dystrophic 
but distinct 7.0-kb bFGF transcript in PI0 uncultured RPE RCS strains, we looked for evidence of functional impairment 
from both rat strains. A slightly stronger bFGF signal was in the developing mutant eyes. Basic FGF is a very potent 
seen in the cultured RPE cells. All of the signals, however, effector of biological processes in developing systems and con- 
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trol of angiogenesis is one of its well known functions [29]. In 
the eyes of normal neonatal rats, choroidal angiogenesis is 
known to occur during the second postnatal week [30,31]. 
We reasoned that if the observed decrease in bFGF expression 
were functionally significant, it might have detrimental effects 
on this process. This hypothesis was tested using histological 
sections of eyes of P7-12 pups fixed by perfusion with mixed 
aldehydes, and whole mounts of choroid-lined eyecups from 
7-14-day-old pigmented animals (Fig. 3). In both normal and 
dystrophic eyes, the choroid and sclera were undifferentiated 
at P7 (Fig. 3a,b). In the normal pups, the choriocapillaris and 
the vortex venous system were seen to develop explosively 
within the subsequent l-3 days (Fig. 3~). By contrast, chor- 
oidal tissue remained relatively undifferentiated in PlO dys- 
trophic pups (Fig. 3d). In the developing choroid of pigmen- 
ted rats, the connective tissue spaces become filled with darkly 
pigmented melanocytes which intimately surround the form- 
ing vasculature (Fig. 3~). 
The distribution of the developing vasculature was observed 
by transmitted light and phase contrast microscopy of whole 
mounts of choroid-lined eyecups from 24 eyes sampled from 
six normal litters and 44 eyes from seven dystrophic litters, 
ranging in age from P7 to Pll. In both normal and mutant 
rats, developing choroidal vessels arose as sprouts extending 
from three main vessels, surrounded by dense clusters of mel- 
anocytes. At all ages examined, the number of forming vessels 
was obviously reduced in the dystrophic eyecups relative to 
age-matched controls (compare Fig. 3e,f). Furthermore, the 
distribution of those vessels that formed was often markedly 
less organized than in normals. The number of branches 
sprouting from each of the main vessels was quantitated in 
choroids of 8- and lo-day-old normal and mutant rats (Fig. 
4). As expected, results revealed increasing choroidal angio- 
genesis between P8 and PlO in the normal rat strain, but 
significantly, total counts of vessels in choroids of mutant 
P8 and PlO rats were only 21% and 27% respectively, of con- 
trol values (Fig. 4). 
In light of the above indications of reduced bFGF expres- 
sion in the mutant neonatal RPE, and delayed or abnormal 
development of choroidal vessels in pups of this age, an ana- 
lysis of the bFGF gene in the RCS rat was undertaken. The 
gene was first examined in DNA from control and dystrophic 
RCS rats by Southern analysis, to look for gross abnormal- 
ities such as a deletion or rearrangement. High-molecular- 
weight genomic DNA from control and RCS rats was di- 
gested with various combinations of restriction enzymes and 
subjected to Southern blot analysis with the RT-PCR-ampli- 
fied bFGF probe. The results revealed identical bands in the 
two congenic rat strains (data not shown). Denaturing gradi- 
ent gel electrophoresis (DGGE) was next used to search for 
single point mutations; this analysis was conducted at two 
levels, i.e. on the bFGF gene and the transcript. As described 
in Section 2, the selected PCR primers were predicted to am- 
plify the putative three exons of the rat bFGF gene (Fig. 5a). 
Following PCR amplification of genomic DNA from dys- 
trophic and control rats using these primers, products of ex- 
pected size were obtained and partially sequenced, confirming 
the suspected similarity in structure of the rat and human gene 
sequences (data not shown). DGGE analysis of the PCR 
products representing the three exons revealed no differences 
in the bFGF exonic sequences of mutant and control RCS rat 
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Fig. 2. Northern blot analysis of bFGF expression in uncultured 
neonatal rat RPE and normal RPE cell line. (a) 10 pg of total 
RNA from freshly isolated RPE sheets from PlO RCS-rdy+p+ nor- 
mal rats (lane l), PlO dystrophic RCS-p+ rats (lane 2) or cultured 
BPEI-1 normal rat RPE cells (lane 3) was electrophoresed, blotted, 
and hybridized with 32P-labeled RT-PCR-amplified bFGF probe 
(upper panel), or B-actin probe (lower panel) and autoradiographed. 
Arrow indicates a faint 7.0 kb bFGF message present in each lane, 
but most prominent in lane 3. (b) Densitometric analysis of relative 
hybridization intensity of bFGF and actin in autoradiographs 
shown in (a). Results show slightly more than twofold reduction in 
bFGF expression in lane 2 (PlO mutant RPE) vs. lane 1 (PlO nor- 
mal RPE). 
volving guanine and cytosine residues can sometimes be 
missed by DGGE, the corresponding PCR products from 
normal and mutant DNA were mixed and analyzed for the 
production of potential heteroduplex molecules. The result 
again indicated absence of any mutation (Fig. 5b, lanes 7-9). 
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Fig. 3. Analysis of choroidal angiogenesis in developing eyes of pigmented normal (N) and dystrophic (D) RCS rat pups. (ad) H+E-stained 
paraffin sections of eyes from normal and mutant rat pups perfusion fixed on the indicated postnatal (P) day, showing the appearance of the 
posterior wall of the globe close to the optic nerve head. Bar, 100 pm (a-d). Black vertical arrows in (a,b) indicate extent of the undifferen- 
tiated choroid+sclera on P7; white vertical arrows in (c,d) show the width of the differentiating choroid on PlO. rpe, retinal pigment epithe- 
lium; inl, inner nuclear layer; onl, outer nuclear layer; cc, choriocapillaris; cv, choroidal vessel; s, sclera; m, extraocular muscle. In PlO normal 
pups (c), but not mutants (d), an extensive network of choroidal vessels has developed, intimately surrounded by stroma containing abundant 
heavily pigmented melanocytes. (e,f) Views of representative whole mounts of choroid-lined eyecups, prepared following enzymatic removal of 
the RPE layer from eyes of pigmented rat pups: (e) P8 normal, N; (f) P8 dystrophic, D. Insets show similar preparations (P8 N, P7 D) at low 
power. Bar, 2.50 pm (e,f) and 1100 pm (insets). The distribution of the developing choroidal vessels is revealed as light lines and streaks cours- 
ing through heavily pigmented stroma (dark areas). onh, optic nerve head. Choroidal vessels are abundant in the normal eyes (e) in contrast 
with the mutant eyes (0. 
Because the PCR primers had to be designed from exonic 
sequences, the above analysis of the putative exons missed the 
20 bp of exonic sequence flanking each intron (Fig. 5a). Thus 
mutational analysis was also conducted on the bFGF tran- 
script by RT-PCR amplification of RNA isolated from con- 
trol and dystrophic rat RPE cell lines [16], using primers de- 
signed to amplify fragments (Rl and R2) containing the 
missed sequences (Fig. 5a). RT-PCR products of expected 
size were obtained from RNA of both RPE cell lines and 
DGGE analysis again showed no difference between the 
RCS and control sequences (Fig. 5c, lanes l-4). The R2 prod- 
uct was also subjected to potential heteroduplex formation 
and analyzed but showed no mutation (Fig. 5c, lane 5). 
Thus, the coding region of the bFGF gene in the RCS rat 
appeared to be intact. 
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Fig. 4. Quantitation of angiogenesis in whole mounts of choroid- 
lined eyecups from pigmented normal (N) and dystrophic (D) RCS 
rat pups. Counts were made, at the indicated postnatal ages, of ves- 
sels sprouting from the three main vessels (Vl, V2, V3) which form 
foci of angiogenesis in the differentiating choroid. T (hatched bars), 
total counts of vessels. The reduction in T in mutant pups, relative 
to normals, is highly significant (P<O.O05, Student’s t-test) at both 
P8 and PlO. 
4. Discussion 
The function of bFGF in the developing and mature retina, 
RPE and choroid is not yet well understood. However, the 
possibility of a defect in bFGF as the primary defect in this 
model is an attractive hypothesis for several reasons. First, the 
retinal dystrophy begins while the eye is still developing. Dur- 
ing the second postnatal week, the photoreceptor outer seg- 
ments begin to form, and phagocytosis and other normal 
interactions between RPE and photoreceptors are becoming 
established [32,8]. The RPE differentiates to its mature state, 
the underlying Bruch’s membrane is elaborated and the chor- 
oid undergoes maturational changes, including angiogenesis 
involving development of the specialized fenestrated capil- 
laries of the choriocapillaris, which supply the RPE and outer 
retina [30,31]. It is reasonable to hypothesize therefore that 
bFGF, an important factor in development, might play a 
central role in one or more of these processes. Secondly, 
from the original chimera experiment there was indication 
that the normal rdy gene product is a diffusible factor [2]. 
Finally, studies from our laboratory using primary cultures 
of neonatal normal and dystrophic rat RPE have shown 
that exogenously added bFGF can reverse the outer segment 
phagocytic defect, the hallmark of dystrophic rat RPE cells in 
vitro*. 
Since the RPE is known to be the primary site of the genet- 
ic defect in RCS rats [2], in this study we evaluated the status 
of bFGF in normal and dystrophic RPE from P7 to P14, 
which spans the critical period in rat retinal development dur- 
ing which the RCS phagocytic defect first appears. Assessment 
of bFGF immunoreactivity in the transparent eyecup prepara- 
tions was quite informative, in that first, the reaction of all 
*McLaren, M.J., Holderby, M., Brown, M.E. and Inana, G. (1992) 
Invest. Ophthalmol. Vis. Sci. 33 (Suppl.), 1027; McLaren, M.J. and 
Inana, G. (1995) Invest. Ophthalmol. Vis. Sci. 36 (Suppl.), 866. 
RPE cells in the intact monolayer could be viewed en face and 
second, without the need to section the RPE cells, potential 
loss of this soluble factor during processing was greatly re- 
duced. Previous studies have shown specific immunostaining 
of bFGF in rat RPE using a variety of antibodies including an 
antipeptide antibody recognizing the first 24 amino acids of 
the bovine and human bFGF sequence [33,34]. In our inves- 
tigation, immunofluorescent staining of bFGF in RPE both in 
situ and in isolated sheets clearly demonstrated a marked re- 
duction of immunoreactivity, relative to RPE cells from age- 
matched normals, in dystrophic RPE analyzed from P7-P14. 
Our results on bFGF immunolocalization in normal and dys- 
trophic rats of this age differ from those of Connolly et al. 
[34], obtained using paraffin or frozen sections of paraformal- 
dehyde-fixed retinas of 19 different ages from PO to P90; in 
that study no staining differences between the two strains were 
noted at any age. Nevertheless, the authors suggested that the 
RCS retinas might possess a relative deficit in bFGF too small 










Fig. 5. PCR amplification of the rat bFGF gene and message, and 
analysis by DGGE. (a) Based on structure of the human gene, indi- 
cated PCR primers were designed for the amplification of the three 
predicted coding exons of the rat bFGF gene. Primers were also de- 
signed to amplify overlapping fragments (Rl and R2) of the rat 
bFGF cDNA. See text for details. (b) DGGE analysis of the PCR- 
amplified exonic sequences from normal (lanes 1,3,5) and dystrophic 
(lanes 2,4,6) rat DNA. To produce potential heteroduplex bands, 
normal and dystrophic products were mixed and analyzed (lanes 
7,8,9). No differences in migration are seen (lanes l-6) and hetero- 
duplexes are not observed (lanes 7-9). (c) RT-PCR amplification 
and DGGE of normal (lanes 1,3) and dystrophic (lanes 2,4) RPE 
cell line RNA in two overlapping fragments i.e. Rl (lanes 1,2) and 
R2 (lanes 3,4). The R2 RT-PCR products were also mixed and ana- 
lyzed for heteroduplex formation (lane 5). No differences are ob- 
served between the normal and dystrophic RT mRNA samples. 
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the published figures showing a few cross-sectioned RPE cells, 
there is evidence of variable expression of bFGF from one 
RPE cell to the next. Such variations, which we observed in 
intact PlO-12 RPE of normal rats, are of course more easily 
appreciated when viewing the entire RPE monolayer en face. 
Alternatively, the apparent differential bFGF expression we 
observed in RPE monolayers in situ and in freshly isolated 
RPE cells from P7 to P14 may be specific to the particular 
developmental window which we were studying in detail. 
The level of bFGF mRNA is known to be quite low in 
most mature tissues, making it difficult to study bFGF expres- 
sion at the message level [35-371. This was certainly borne out 
in our experiments with uncultured RPE cells, since only a 
barely detectable signal was obtained by Northern analysis of 
RNA from 10 day old rats. Nevertheless, a twofold reduction 
in the level of message was observed in the RCS RPE com- 
pared to congenic controls, based on results from over 100 
eyes from 5-7 litters per sample. Another group previously 
used RT-PCR to compare bFGF expression in cultured 
RPE from neonatal rat pups, following growth of the cells 
for 10 days in vitro, and in contrast to our results with freshly 
isolated RPE, found no difference between normal and dys- 
trophic cells under these conditions [38]. It is known that 
bFGF levels can vary significantly once cells are removed 
from their natural environment and cultured [39-411; thus 
the most likely explanation for our differing results might 
simply be the difference between uncultured and cultured 
RPE cells. Because of the possibility of culture-induced 
changes in bFGF expression, uncultured RPE cells were 
used here as the source of RNA for evaluation of expression 
of this gene in vivo, which, as shown in the results, appeared 
to be downregulated in the RPE of mutant rat pups. 
A theoretical cause of a bFGF protein and mRNA deficit in 
the RCS RPE, as shown here, could be a mutation in the 
coding sequence of the bFGF gene: either gross, such as a 
deletion or rearrangement, or more subtle, such as a nonsense 
codon mutation resulting in a message with reduced stability 
or expression level, as shown for mutations in ornithine ami- 
notransferase in gyrate atrophy [27]. Alternatively, a mutation 
in the promoter region could also result in reduced expression 
or loss of inducibility. The failure in this study to detect any 
differences between the normal and dystrophic bFGF genes 
by Southern analysis and between the exons and RT mRNAs 
by DGGE essentially rules out the possibility of a mutation in 
the coding sequence, although the possible existence of a pro- 
moter mutation has not been excluded. An alternate explana- 
tion for these results is that bFGF expression may be down 
regulated in the mutant RPE as a result of a mutation in 
another RPE-expressed gene, i.e. the as yet unknown rdy 
gene. 
Although it may not be the primary genetic defect in the 
RCS rat, the reduction of bFGF expression shown here could 
have significant ramifications, occurring as it does during a 
critical developmental period for the outer retina and under- 
lying choroid. The data presented here from the analysis of 
choroidal vasculature in perfusion-fixed eyes and whole 
mounts of choroid provide the first demonstration that chor- 
oidal angiogenesis is abnormal in neonatal RCS rats. Inter- 
estingly, the choroidal defect, evident from P8 or earlier, pre- 
dates the phagocytic defect in these developing eyes by at least 
four days [8]; thus this is the earliest known abnormality to be 
detected in the differentiating eyes of these mutant rats. It has 
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been previously proposed that maintenance of the chorioca- 
pillaris is under control of the RPE [42]. Recently it has been 
demonstrated using an in vitro model of choroidal angiogen- 
esis that elongation of choroidal endothelial tubes is stimu- 
lated by coculture with RPE, and inhibited by neutralizing 
antibodies against angiogenic factors including bFGF [43]. 
We have shown in this study that abnormal choroidal angio- 
genesis in RCS rat pups is coincident with reduced bFGF 
expression by the RPE. This result is consistent with the hy- 
pothesis that bFGF expression by the RPE may play a central 
role in the normal postnatal development of the choroidal 
blood supply in the rat eye. Further studies are required to 
test the involvement of this pluripotential growth and differ- 
entiation factor in choroidal angiogenesis, RPE phagocytosis, 
and other processes that are becoming established at this crit- 
ical stage of ocular differentiation. 
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